Edition:
United States

Selecta Biosciences Inc (SELB.OQ)

SELB.OQ on NASDAQ Stock Exchange Global Market

13.30USD
11:52am EDT
Change (% chg)

$0.59 (+4.64%)
Prev Close
$12.71
Open
$12.69
Day's High
$13.30
Day's Low
$12.68
Volume
19,809
Avg. Vol
75,744
52-wk High
$24.00
52-wk Low
$8.00

Chart for

About

Selecta Biosciences, Inc. is a clinical-stage biopharmaceutical company. The Company using its synthetic vaccine particle (SVP) technology to discover and develop targeted therapies that are designed to modulate the immune system to treat rare and serious diseases. The Company is engaged in the research and development of... (more)

Overall

Beta: --
Market Cap(Mil.): $435.97
Shares Outstanding(Mil.): 22.07
Dividend: --
Yield (%): --

Financials

  SELB.OQ Industry Sector
P/E (TTM): -- 85.36 32.76
EPS (TTM): -2.86 -- --
ROI: -59.00 2.21 14.61
ROE: -72.01 3.85 16.34

Exclusive: KKR preps vending machine operator Selecta for $1 billion IPO - sources

FRANKFURT/LONDON Buyout group KKR has started preparations to list vending machine operator Selecta on the Swiss bourse as soon as the fourth quarter of 2018, people close to the matter said, adding to a flurry of major listings in the country.

Jun 26 2018

BRIEF-Selecta Biosciences Announces Q1 Loss Per Share $0.71

* SELECTA BIOSCIENCES ANNOUNCES FIRST QUARTER 2018 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

May 09 2018

BRIEF-Selecta Biosciences Qtrly Loss Per Share $0.88

* SELECTA BIOSCIENCES ANNOUNCES FOURTH QUARTER AND YEAR END 2017 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

Mar 15 2018

BRIEF-Selecta Appoints ‍Gabriel Pirona As New Chief Financial Officer

* ‍HUGUES ROUGIER WILL RESIGN FROM HIS ROLE AS CHIEF FINANCIAL OFFICER

Mar 14 2018

Competitors

Earnings vs. Estimates